Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-22
2006-08-22
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210210, C548S207000, C548S217000, C548S950000
Reexamination Certificate
active
07094777
ABSTRACT:
Compounds of formula I:are antagonists of the human 5-HT2Areceptor, and hence useful in treatment or prevention of a variety of neurological conditions.
REFERENCES:
patent: 4128552 (1978-12-01), Wise et al.
patent: 4218455 (1980-08-01), Wise et al.
patent: 6194406 (2001-02-01), Kane et al.
patent: 6479279 (2002-11-01), Achard et al.
patent: 6479479 (2002-11-01), Achard et al.
patent: 6872717 (2005-03-01), Achard et al.
patent: 0261688 (1987-09-01), None
patent: 0304888 (1988-08-01), None
patent: 0330826 (1989-01-01), None
patent: WO 96/35666 (1996-04-01), None
patent: WO 00/43362 (2000-07-01), None
S. Fletcher, et al, “4-(Phenylsulfonyl)piperidines: Novel, Selective, and Bioavailable 5-HT2A Receptor Antagonists”, J. Med. Chem., 25, 492-503 (2002).
Chambers Mark Stuart
Curtis Neil Roy
MacLeod Angus Murray
Maxey Robert James
Szekeres Helen Jane
Barker Michael P.
Merk Sharp & Dohme Ltd.
Saeed Kamal
Thies J. Eric
Winokur Melvin
LandOfFree
5-HT 2A receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT 2A receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT 2A receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3636655